Search

everythinglearnresearchcommunity

for

Search:↓

The combined treatment effectively managed severe skin issues in Olmsted syndrome.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Ixekizumab may be an effective first treatment for a rare skin condition causing hair loss.

Baricitinib may effectively treat oral lichen planus.

Baricitinib slightly increased cholesterol levels in alopecia areata patients, but these changes were manageable.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

Suplatast tosilate successfully treated a woman's systemic sclerosis symptoms.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

High-dose intravenous iron therapy doesn't interfere with treatment improvements in IBD patients with iron deficiency anemia.

Ixekizumab quickly and effectively clears palmoplantar psoriasis in both adults and children.

Hydroxychloroquine may help COVID-19 patients with lupus.

Intralesional triamcinolone acetonide can effectively limit the progression of GLPLS.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

A multi-drug treatment can effectively clear extensive calcinosis in juvenile dermatomyositis.

Prednisone treatment helped a woman with Cronkhite-Canada syndrome recover from hair loss and digestive issues.

Switching from adalimumab to ixekizumab improved a patient's psoriasis and reversed hair whitening.

The new SLICC criteria for diagnosing lupus are more sensitive and accurate than the old criteria.

Methotrexate plus prednisolone had the fewest serious side effects.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.

Baricitinib improved hair loss and arthritis in a lupus patient.

Leflunomide with prednisone is effective and well-tolerated for lupus nephritis when cyclophosphamide can't be used.

Ritlecitinib successfully treated a child's alopecia universalis after baricitinib failed.

Deucravacitinib improves symptoms and reduces inflammation in Lichen Planopilaris.

Sacituzumab govitecan improves quality of life and symptoms in breast cancer patients, except for causing more diarrhea.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.